Gujarat Narmada Valley Fertilizers& Chemicals Limited (India)

Basis: standalone, INR Cr, FY2022–FY2026, from Screener.in (compiled from annual reports). FY2025 and FY2026 are cross-checked against GNFC results releases.

• Minor discrepancy: Screener shows FY2025 PAT of INR 586 Cr; the company reports INR 585 Cr.

• Indian GAAP/Ind-AS presentation does not report "gross profit". It is marked not disclosed.

• "Operating profit / EBITDA" excludes other income (Screener convention).

Income statement

Gross profit: not publicly disclosed (Ind-AS format).

Other data points:

• FY2026 consolidated PAT was INR 808 Cr (consolidated EPS INR 54.97) versus INR 597 Cr in FY2025.

• FY2026 total income was INR 8,272 Cr (FY2025: INR 8,393 Cr).

Margins and growth

Revenue CAGR:

• FY2022–FY2026 (4-year): −2.6%.

• FY2021–FY2026 (5-year, FY2021 revenue INR 5,129 Cr): +8.7%.

• 10-year: about 6% (Screener).

Balance sheet

Notes on the balance sheet:

Short/long debt split: Not applicable; debt was negligible throughout.

Cash and liquid assets: At FY2026: bank deposits INR 1,111 Cr (FY2025: INR 2,308 Cr), cash and cash equivalents INR 74 Cr, investments INR 1,558 Cr (GNFC release). Gross cash was INR 2,782 Cr at 30 Sep 2023 (Value Research, buyback note).

Reclassification: The FY2026 fall in bank deposits and investments alongside a rise in "other assets" (INR 2,916 Cr to INR 4,775 Cr) likely reflects reclassification into current financial assets or subsidy receivables.

Net debt: Deeply negative (net cash) in every year. On FY2026 disclosed liquid assets of about INR 1,185 Cr (deposits plus cash, excluding investments), net cash is at least about INR 1,185 Cr (derived).

Goodwill & intangibles: Not material / not separately disclosed.

Working capital: Working-capital days rose from 61 (FY2025) to 188 (FY2026) per Screener, consistent with the "other assets" increase.

Cash flow

Notes:

• Dividends paid are derived as the prior-year DPS × shares outstanding.

• The FY2024 financing outflow (INR 1,281 Cr) reconciles approximately to dividends (about INR 466 Cr), the buyback (INR 653 Cr) and buyback distribution tax (not separately verified).

• The FY2024 positive investing cash flow reflects liquidation of investments and deposits to fund the buyback.

• Company-reported FY2025 CFO is INR 606 Cr.

Ratios

Other ratios:

ROIC: Not separately disclosed. On an after-tax basis excluding treasury assets, ROIC tracks ROCE minus the drag from idle cash, so operating ROIC is higher than reported ROE.

Net debt / EBITDA: Negative (net cash) in all years.

Quarterly run-rate (standalone, INR Cr)

Notes:

• Q2 FY2026 revenue and PAT are derived by subtracting the other quarters from the FY2026 totals.

• Q4 FY2026 EBITDA was INR 482 Cr (21.8% margin) versus INR 240 Cr (11.7%) in Q4 FY2025.

• Q3 FY2026 EBITDA was INR 180 Cr (9.1%).

• Q1 FY2026 was depressed by the annual turnaround at the Bharuch complex.

Trend commentary

Cycle. GNFC's five-year record is a textbook commodity cycle.

• FY2022–FY2023 were super-cycle years. Post-COVID restocking and the 2022 energy shock lifted global TDI, acetic acid, methanol and ammonium nitrate prices. Operating margins peaked at 28% (FY2022) and PAT at INR 1,704 Cr.

• FY2024 brought the downcycle. Chinese capacity additions and a "buyers' market" (management's description, May 2024) cut realizations sharply. Simultaneous NBS subsidy reductions hit complex-fertilizer margins. EBITDA collapsed 73% to INR 502 Cr.

• FY2025–FY2026 show a gradual recovery driven by lower input costs rather than revenue: revenue was flat to slightly down, while EBITDA rose 75% from FY2024 to FY2026.

Inflection. The Q4 FY2026–Q1 FY2027 period is a clear inflection. Disruption of Middle East supply in March 2026 tightened global chemical markets and lifted GNFC's realizations. At the same time the company's own inputs (coal, a large part of energy cost, and pooled gas) did not rise proportionately. Quarterly PAT averaged about INR 350 Cr over these two quarters versus about INR 150 Cr in FY2025. Q1 FY2027 was the second-best quarter in company history after Q1 FY2022 (management, Aug 2026 call).

Quality of earnings. Other income (treasury yield on deposits and investments) made up 47–72% of PBT in FY2024–FY2026. This is a structural feature of a cash-rich, low-leverage state enterprise. It also means operating ROCE is better than consolidated ROE suggests.

Capex step-up. Capex was flat at INR 140–250 Cr a year through FY2024. It rose to about INR 450–550 Cr in FY2025–FY2026, and CWIP reached INR 900 Cr. Management guides about INR 2,800 Cr for FY2027 alone, roughly 4.3x FY2026 operating cash flow. FY2027 free cash flow will almost certainly be negative and will draw down treasury assets.

Capital returns. GNFC returned about INR 1,119 Cr in FY2024 through dividends plus the buyback, and has paid out 39–50% of earnings since FY2023. State PSU dividend mandates in Gujarat underpin this (Value Research, Nov 2023).

Management guidance (summary)

Consensus growth expectations: not publicly disclosed (no consensus in sources reviewed).

Analyst run-rate (illustrative, not a forecast): If Q1 FY2027 PAT (INR 310 Cr) were sustained, adding the energy-norm and CCPP benefits and subtracting normalising realizations, FY2027 PAT would land in a wide INR 900–1,300 Cr range. Sensitivity to chemical prices is very high.

Bull case

1. Earnings inflection with policy and cost tailwinds. The energy norm (about INR 61 Cr a quarter) and CCPP savings (INR 10–12 Cr a month) together add a structural INR 350–400 Cr annualised to pre-tax profit at run-rate, before any chemical price improvement. That is roughly 33–38% of FY2026 PBT (INR 1,065 Cr).

2. Cheap balance-sheet-backed valuation. The stock trades at about 1.0x book and about 6.8x EV/EBITDA, with zero debt and liquid assets of about INR 2,700 Cr (about 30% of market cap) plus a 3.6% dividend yield.

3. Volume growth after years of stagnation. FY2027 capacity additions (ammonia +50 KTPA, WNA-III 200 KTPA, AN-II 163 KTPA) and a 150–600 KTPA acetic acid pipeline target import-dependent Indian markets (85% import share in acetic acid).

Bear case

1. Windfall reversal. Q4 FY2026–Q1 FY2027 profits were boosted by geopolitical supply tightness. Normalisation, or renewed Chinese oversupply as in FY2024 (EBITDA −73%), would compress chemical margins quickly.

2. Capital allocation risk. FY2027 capex of about INR 2,800 Cr is roughly 4x operating cash flow. It is directed by a government-controlled board with four MD changes in about nine months. Returns on new projects (BPA, polyols) in globally oversupplied chains are uncertain, and treasury drawdown removes the other-income cushion (INR 499 Cr in FY2026).

3. Structural fertilizer drag and gas risk. Urea remains loss-making without fixed-cost revision. RLNG supply is exposed to Hormuz-type disruptions (60% DCQ from March 2026), and the shift to coal raises the carbon-transition liability.

Key catalysts and monitorables (next 12 months)

Concluding analyst verdict

GNFC enters FY2027 at the strongest operating point it has reached since the FY2022–FY2023 super-cycle, and it carries a balance sheet that few Indian commodity chemical producers can match.

• The chemicals segment generated INR 913 Cr of segment profit in FY2026, on flat revenue.

• The company is debt-free and holds liquid assets of roughly INR 2,700 Cr.

• Q1 FY2027 PAT of INR 310 Cr, management's second-best quarter ever, shows how much operating leverage exists when import-parity prices rise against a partly coal-based cost base.

Two policy and cost levers are now concrete. The new urea energy norm is worth about INR 61 Cr a quarter, and the Dahej CCPP should save INR 10–12 Cr a month. Together they should narrow the chronic fertilizer drag and lower TDI costs regardless of the price cycle.

Three caveats keep this a cyclical value story rather than a compounding one:

1. Earnings quality is hostage to commodity prices. Much of the recent margin expansion reflects geopolitically tightened global supply, which can reverse within quarters, as FY2024 showed when EBITDA fell 73%.

2. Capital allocation is about to become the dominant variable. A roughly INR 2,800 Cr FY2027 programme, plus prospective BPA, polyols and acetic acid projects, will consume most of the treasury cushion that currently supplies about half of pre-tax profit. These decisions sit with a state-controlled board whose managing directors have rotated four times in under a year.

3. Feedstock risk has been demonstrated, not just theorised. The March 2026 RLNG force majeure proved the exposure, and the strategic response (coal, gasification) trades cost security for higher carbon intensity.

At about 1.0x book, about 8–11x earnings and a 3.6% yield, the market already discounts much of this. The stock's re-rating path depends on disciplined, disclosed-IRR project sanctioning by end-2026 and evidence that FY2027 profits hold as global chemical markets normalise. The rating is constructive on the near-term earnings trajectory and neutral on long-term value creation until capital allocation and leadership continuity are demonstrated.

---

SOURCES (principal)

1: GNFC Q4/FY2026 audited results and segment disclosure, 18 May 2026 (via ScanX, Kotak Neo, Zee Business, Indian Chemical News, Trade Brains) — FY2026 P&L, segments, balance sheet, cash flow, capex projects, dividend, auditors

2: GNFC investor/analyst call, 19 May 2026 (ScanX summary) — FY2027 capex, CCPP and project timelines, urea outlook

3: GNFC Q1 FY2027 results, 5 Aug 2026 (NSE filing; InvestyWise; Sahi; Univest) — Q1 FY2027 figures, NCU energy norm, GMDC MoU, cost auditor

4: GNFC Q1 FY2027 earnings call transcript, 6 Aug 2026 (InvestyWise summary) — Second-highest quarterly profit; segment commentary

5: Screener.in, GNFC standalone financials FY2015–FY2026 — Multi-year P&L, balance sheet, cash flow, ratios

6: GNFC Reg. 30 filing, force majeure, 6 Mar 2026 (NSE); Goodreturns; AgroSpectrum; Chemindigest — RLNG curtailment and industry impact

7: GNFC management-change filings, Dec 2025 – Sep 2026 (NSE/BSE; Business Standard PDF; Business Today; InvestyWise; Sahi; ScanX; FilingReader) — Board and MD changes

8: GSFC / GSPL / Gujarat Gas filings, 1 Nov 2025 — Pankaj Joshi resignation

9: INEOS press release, Nov 2024; Chemical Weekly, Dec 2024; Bajaj Broking — Acetic acid JV, 150 KTPA existing plant, 85% import share

10: 5paisa / Value Research, Nov 2023 — Buyback terms

11: Valueinvesting.io; 5paisa; HDFC Sky — Dividend history

12: Upstox, Dhan, MarketsMojo, IIFL, Tapetide — Shareholding pattern Jun 2026

13: ICRA rating rationale; Acuité rating rationale, Feb 2024 — Credit ratings and business characterisation

14: Business Standard / ICICIdirect, May 2024 — FY2024 results and segment commentary

15: Anand Rathi, Business Today, Fyers, Upstox, Fintel — Share prices and returns

16: GSFC FY2026 results (Outlook Business, Trendlyne); Deepak Fertilisers FY2026 results (Kotak Neo, FilingReader, NSE) — Peer benchmarking

17: ScanX ESG rating items, Mar–Apr 2026 — ESG ratings